Sifting through countless of stocks in the Health Care Providers & Services industry can be tedious, and sometimes two stocks are just too similar to judge which is the better investment. If you’re on the fence about investing in HCA Healthcare, Inc., Henry Schein or Inc. because you’re not sure how they measure up, it’s important to compare them on a few factors before making your decision.

Read on to learn how HCA Healthcare, Inc., Henry Schein and Inc. compare based on key financial metrics to determine which better meets your investment needs.

About HCA Healthcare, Inc., Henry Schein and Inc.

HCA Healthcare, Inc., through its subsidiaries, provides health care services in the United States. The company owns, manages, and operates hospitals, ASCs, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, radiation and oncology therapy centers, as well as rehabilitation and physical therapy centers, physician practices, home health agencies, hospices, outpatient physical therapy providers, home and community-based services providers, and various other facilities. Its general and acute care hospitals offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic services, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.

Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments. The Global Distribution and Value-Added Services segment distributes infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, gypsum, acrylics, articulators, abrasives, PPE products, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, dental chairs, delivery units and lights, digital dental laboratories, X-ray supplies and equipment, and high-tech and digital restoration equipment, as well as provides equipment repair services, financial services on a non-recourse basis, continuing education services for practitioners, consulting, and other services. It also markets and sells a portfolio of consumable merchandise under its own corporate brand. The Global Specialty Products segment engage in manufacturing, marketing, and sales of dental implant and biomaterial products; and endodontic, orthodontic and orthopedic products, and other health care-related products and services. The Global Technology segment is involved in the development and distribution of practice management software, e-services, and other products which are distributed to health care providers. The company serves dental practices, laboratories, physician practices, and ambulatory surgery centers, as well as government, institutional health care clinics, home health providers, and other alternate care clinics. It has a strategic partnership with GoTu Technology to help dental practices address ongoing staffing challenges. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.

Latest Health Care Providers & Services and HCA Healthcare, Inc., Henry Schein, Inc. Stock News

As of July 30, 2026, HCA Healthcare, Inc. had a $85.7 billion market capitalization, compared to the Health Care Providers & Services median of $1.9 million. HCA Healthcare, Inc.’s stock is down 13.8% in 2026, up 5.3% in the previous five trading days and up 14.89% in the past year.

Currently, HCA Healthcare, Inc.’s price-earnings ratio is 13.2. HCA Healthcare, Inc.’s trailing 12-month revenue is $78.0 billion with a 8.8% net profit margin. Year-over-year quarterly sales growth most recently was 8.7%. Analysts expect adjusted earnings to reach $29.559 per share for the current fiscal year. HCA Healthcare, Inc. currently has a 0.8% dividend yield.

As of July 30, 2026, Henry Schein, Inc. had a $9.7 billion market cap, putting it in the 77th percentile of all stocks. Henry Schein, Inc.’s stock is up 13.5% in 2026, up 0.3% in the previous five trading days and up 21.57% in the past year.

Currently, Henry Schein, Inc.’s price-earnings ratio is 25.8. Henry Schein, Inc.’s trailing 12-month revenue is $13.4 billion with a 3.0% net profit margin. Year-over-year quarterly sales growth most recently was 6.3%. Analysts expect adjusted earnings to reach $5.344 per share for the current fiscal year. Henry Schein, Inc. does not currently pay a dividend.

How We Compare HCA Healthcare, Inc., Henry Schein and Inc. Stock Grades

Stock evaluation requires access to huge amounts of data and the knowledge and time to sift through it all, make sense of financial ratios, read income statements and analyze recent stock movements. AAII created A+ Investor, a robust data suite that condenses data research in an actionable and customizable way suitable for investors of all knowledge levels, to help investors streamline and work through such data.

AAII’s proprietary stock grades come with A+ Investor. These offer intuitive A‐F grades for each of five key investing factors: value, growth, momentum, earnings estimate revisions and quality. Here, we’ll take a closer look at HCA Healthcare, Inc., Henry Schein and Inc.’s stock grades to see how they measure up against one another.

Learn more about A+ Investor here!

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

HCA Healthcare, Inc., Henry Schein and Inc. Stock Value Grades

Company	Ticker	Value
HCA Healthcare, Inc.	HCA	A
Henry Schein, Inc.	HSIC	C

Successful stock investing involves buying low and selling high, so stock valuation is an important consideration for stock selection.

Buying stocks that are going to go up typically means buying stocks that are undervalued in the first place, although momentum investors may argue that point.

AAII’s A+ Investor Value Grade derives from a stock’s value score. The Value Score is the percentile rank of the average of the percentile ranks of the price-to-sales ratio, price-earnings ratio, enterprise-value-to-EBITDA (EV/EBITDA) ratio, shareholder yield, price-to-book-value ratio and price-to-free-cash-flow ratio. The score is variable, meaning it can consider all six ratios or, should any of the six ratios not be valid, the remaining ratios that are valid. To be assigned a Value Score, stocks must have a valid (non-null) ratio and corresponding ranking for at least two of the six valuation ratios.

Stocks with a Value Score from 81 to 100 are considered deep value, those with a score between 61 and 80 are a good value and so on.

HCA Healthcare, Inc. has a Value Score of 86, which is Deep Value. Henry Schein, Inc. has a Value Score of 56, which is Average.

The Value Stock Winner: HCA Healthcare, Inc.

As you can clearly see from the Value Grade breakdown above, HCA Healthcare, Inc. is considered to have better value than Henry Schein, Inc.. For investors who focus solely on a company’s valuation, HCA Healthcare, Inc. could be a good stock to add to their portfolio. However, it’s important for investors to analyze multiple factors based on a wide range of metrics before deciding whether to buy.

HCA Healthcare, Inc., Henry Schein and Inc. Growth Grades

Company	Ticker	Growth
HCA Healthcare, Inc.	HCA	A
Henry Schein, Inc.	HSIC	B

The foundation of growth investing is seeking out stocks of companies exhibiting strong, consistent and prolonged growth that is expected to continue into the future.

In order to compute the growth score and assign it a letter grade, the percentile ranks for each of three components‐consistency of annual sales growth, five-year sales growth rankings adjusted for extreme levels, and consistency of positive annual cash from operations‐must be determined. These three rank figures are added together, and the sum is ranked against the entire stock universe to arrive at a company’s Growth Score to create an equal distribution of grades.

The companies in the bottom 20% of the stock universe receive Growth Grades of F, considered to be very weak, while those in the top 20% receive A grades, which are considered very strong.

HCA Healthcare, Inc. has a Growth Score of 100, which is Very Strong. Henry Schein, Inc. has a Growth Score of 73, which is Strong.

The Growth Grade Winner: HCA Healthcare, Inc.

As you can clearly see from the Growth Grade breakdown above, HCA Healthcare, Inc. has a more attractive growth grade than Henry Schein, Inc.. For investors who focus solely on how a company is growing relative to other companies in the same industry, HCA Healthcare, Inc. could be a good stock to add to their portfolio. However, it’s important for investors to analyze multiple factors based on a wide range of metrics before deciding whether to buy.

HCA Healthcare, Inc., Henry Schein and Inc.’s Estimate Revisions Grades

Company	Ticker	Earnings Estimate
HCA Healthcare, Inc.	HCA	D
Henry Schein, Inc.	HSIC	C

Earnings estimate revisions scores consider the magnitude of a company’s earnings surprise in its last two reported fiscal quarters. Often, positive surprises beget further positive surprises‐or at least continued sales growth (the exact opposite is generally true, too).

Estimate revisions offer an indication of what analysts are thinking about the short-term prospects of a firm. Estimate revisions are based on the statistical significance of a firm’s last two quarterly earnings surprises and the percentage change in its consensus estimate for the current fiscal year over the past month and past three months.

HCA Healthcare, Inc. has a Earnings Estimate Score of 30, which is Negative. Henry Schein, Inc. has a Earnings Estimate Score of 52, which is Neutral.

The Earnings Estimate Revisions Stock Winner: No Clear Winner

Neither HCA Healthcare, Inc., Henry Schein or Inc. has an Earnings Estimate Revisions Grade that could be considered a “winner.” Investors considering these companies should do additional due diligence and research to see if either could be a good addition to their portfolios. It’s important to look at a wide range of financial metrics in order to determine if HCA Healthcare, Inc., Henry Schein or Inc. is the better investment when it comes to estimate revisions.

Other HCA Healthcare, Inc., Henry Schein and Inc. Grades

In addition to Growth, Value and Estimate Revisions, A+ Investor also provides grades for Momentum and Quality.

Momentum grades help uncover stocks experiencing anomalously high rates of return; research finds that stocks with high relative levels of momentum tend to outperform, whereas those with low levels of momentum tend to continue underperforming.

AAII’s A+ Investor Quality Grade comes from the ranking of key metrics. Specifically, the quality grade is the percentile rank of the composite of return on assets (ROA), return on invested capital (ROIC), gross profit relative to assets, buyback yield, change in total liabilities to assets, accruals, Z double prime bankruptcy risk (Z) score and F-Score.

These 2 key factors, when combined with the above, provide a holistic view into a particular stock. Further, by joining A+ Investor you can see whether HCA Healthcare, Inc., Henry Schein and Inc. pass any of our 60+ stock screens that have outperformed the market since their creation.

So, Which Is the Better Investment, HCA Healthcare, Inc., Henry Schein or Inc. Stock?

Overall, HCA Healthcare, Inc. stock has a Value Score of 86, Growth Score of 100 and Estimate Revisions Score of 30.

Henry Schein, Inc. stock has a Value Score of 56, Growth Score of 73 and Estimate Revisions Score of 52.

Comparing HCA Healthcare, Inc., Henry Schein and Inc.’s grades, scores and metrics can act as a solid basis to determine whether they may be a good investment or not. You’ll also want to look at your portfolio’s asset allocation as well as your risk tolerance and financial goals to see if either of these stocks would make a good fit for you. AAII can help you figure out which investments align with your individual needs and preferences.

Investors are encouraged to do their own due diligence and research. In this way, individuals can effectively become managers of their own assets‐without having to rely on others for financial independence. You can count on AAII for timeless articles on financial planning and stock-picking, unbiased research and actionable analysis.

A+ Investor adds to our qualitative teaching with a powerful data suite to help you whittle down investment choices to find stocks, exchange-traded funds (ETFs) or mutual funds that meet your needs.

AAII Disclaimer

We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown, because past, hypothetical or simulated performance is not necessarily indicative of future results. Before making an investment decision, you should consider your circumstances and whether the information on our content is applicable to your situation. This information was prepared in good faith, and we accept no liability for any errors or omissions. The full disclaimer can be read here.